BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 282895)

  • 1. Prognostic factors in chronic granulocytic leukemia. A study of 798 cases.
    Jacquillat C; Chastang C; Tanzer J; Brière J; Weil M; Pereira-Neto M; Gemon-Auclerc MF; Schaison G; Domingo A; Boiron M; Bernard J
    Boll Ist Sieroter Milan; 1978 Jul; 57(3):237-46. PubMed ID: 282895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
    Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
    Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Old age: a sign of poor prognosis in patients with chronic myelogenous leukemia.
    Kantarjian HM; Keating MJ; McCredie KB; Walters R; Talpaz M; Smith TL; Freireich EJ
    South Med J; 1987 Oct; 80(10):1228-32. PubMed ID: 3477869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic myeloid leukemia: multivariant analysis of initial findings regarding its effect on mean life expectancy].
    Hirschberg T; Berchtold W; Rhyner K; Gmür J
    Schweiz Med Wochenschr; 1985 Dec; 115(52):1881-5. PubMed ID: 3867133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic implication of clinical and histological features in Ph1+ chronic myelocytic leukaemia (CML).
    Thiele J; Fohlmeister I; Vonneguth B; Zankovich R; Fischer R
    Anticancer Res; 1986; 6(6):1401-9. PubMed ID: 3468880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Multivariate analysis of prognostic factors influencing survival in chronic myelogenous leukemia].
    Sakamoto S; Kurata H; Miwa A
    Rinsho Ketsueki; 1989 Aug; 30(8):1180-4. PubMed ID: 2601030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cause of death, survival, and prognostic factors in a series of 98 patients with chronic myeloid leukemia].
    Jonte F; Fernández-Fuertes F; Cecchini C; Luño E; Ordóñez A; Fernández C; Suárez P; Lausín A; Fernández J
    Sangre (Barc); 1992 Oct; 37(5):351-4. PubMed ID: 1293774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Econometric analysis of phase duration for blood morphology and basophil count alterations in chronic granulocytic leukaemia.
    Gola A; Smakowska E; Waszkiewicz L; Błaczkowska A; Kin-Dittmann I; Zielińska K; Czajkowska B; Pajsert E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(3):271-5. PubMed ID: 6205949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party on Chronic Myeloid Leukemia.
    Soverini S; Martinelli G; Rosti G; Bassi S; Amabile M; Poerio A; Giannini B; Trabacchi E; Castagnetti F; Testoni N; Luatti S; de Vivo A; Cilloni D; Izzo B; Fava M; Abruzzese E; Alberti D; Pane F; Saglio G; Baccarani M
    J Clin Oncol; 2005 Jun; 23(18):4100-9. PubMed ID: 15867198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic granulocytic leukemia in blastic crisis. Prognostic factors.
    Sales V; Rojo J; Collazo J; Lagunas E; Aguilar E; Albisua L
    In Vivo; 1991; 5(3):281-5. PubMed ID: 1893082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment prognostic factors and hospitalization periods in childhood acute lymphoblastic leukemia.
    Ramot B; Modan M; Meerowitz Y; Potashnick D; Kende G; Berkowicz M
    Isr J Med Sci; 1982 Apr; 18(4):447-55. PubMed ID: 6953056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in children with acute lymphoblastic leukemia. Part I: Univariate analysis. Children's Cancer and Leukemia Study Group.
    Hiyoshi Y; Fujimoto T; Kuriya N; Otani Y; Mibu K; Yanai M; Sasaki K; Shingaki Y; Yokoyama T; Kadoya S
    Jpn J Clin Oncol; 1985 Mar; 15(1):3-12. PubMed ID: 3856696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Philadelphia chromosome positive adult acute lymphoblastic leukemia: characteristics, prognostic factors and treatment outcome.
    Thomas X; Thiebaut A; Olteanu N; Danaïla C; Charrin C; Archimbaud E; Fiere D
    Hematol Cell Ther; 1998 Jun; 40(3):119-28. PubMed ID: 9698220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relevance of clinical and laboratory data at diagnosis to survival time of chronic granulocytic leukemia patients.
    Kotlarek-Haus S; Frydecka I; Koprowska G; Kuliczkowski K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(6):731-7. PubMed ID: 2436985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of presenting white blood cell count and kinetics of molecular remission in the prognosis of acute myeloid leukemia with CBFbeta/MYH11 rearrangement.
    Martín G; Barragán E; Bolufer P; Chillón C; García-Sanz R; Gómez T; Brunet S; González M; Sanz MA
    Haematologica; 2000 Jul; 85(7):699-703. PubMed ID: 10897121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of bone marrow reticulin fibres in idiopathic myelofibrosis: evaluation of clinicopathological parameters in a scoring system.
    Iványi JL; Mahunka M; Papp A; Kiss A; Telek B
    Haematologia (Budap); 1994; 26(2):75-86. PubMed ID: 7890265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of patients with acute myelogenous leukemia after second salvage therapy.
    Giles F; O'Brien S; Cortes J; Verstovsek S; Bueso-Ramos C; Shan J; Pierce S; Garcia-Manero G; Keating M; Kantarjian H
    Cancer; 2005 Aug; 104(3):547-54. PubMed ID: 15973664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Factors of an unfavorable prognosis in patients with B-cell chronic lymphoid leukemia: a retrospective analysis of 206 cases].
    Nikitin EA; Lorie IuIu; Melikian AL; Samoĭlova RS; Bulycheva TI; Obukhova TN; Kaplanskaia IB; Doronin VA; Kolosova LIu; Goriacheva SR
    Ter Arkh; 2003; 75(7):38-47. PubMed ID: 12934480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Parameters significant for the prognosis of chronic myeloid leukemia in the chronic phase].
    Maras J; Ribicić I; Maras-Simunić M; Skare L
    Acta Med Iugosl; 1990; 44(4):389-97. PubMed ID: 2091442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.